Enhancement of lymphocyte proliferation and IL-2 receptor expression by a processed form (GM-1/P) of monosialoganglioside GM-1

Immunopharmacol Immunotoxicol. 1990;12(4):565-82. doi: 10.3109/08923979009019677.

Abstract

In this study we investigated the ability of GM-1/P, a calcium mediated processed form of monosialoganglioside GM-1, of in vivo augmenting mouse T and B-lymphocyte blastogenesis induced by mitogens. We have also determined its effect on IL-2 responsiveness by analyzing the induction of the expression of IL-2 receptor (IL-2r) on mouse spleen cells. Lymphocyte blastogenesis was evaluated by 3H-TdR incorporation of spleen cells from untreated or GM-1/P (1mg/Kg, i.v., day-1) treated mice cultured in the presence of T (PHA, ConA) B (LPS) cell specific mitogens. The stimulatory effects appeared to be due to a direct action on T and B lymphocytes, since proliferative response was not abolished by removal of macrophages. Splenocytes from GM-1/P treated mice showed increased proliferation in response to various concentrations of HrIL-2; moreover under these conditions an increased generation of LAK activity was found. A direct evidence for enhanced expression of IL-2r was obtained by immunofluorescence and FACS analysis using a monoclonal antibody (PC.61) directed against the p55 subunit of murine IL-2r. 29% PC.61+ cells were found in IL-2 cultures from treated spleen cells.

MeSH terms

  • Animals
  • Cytotoxicity, Immunologic / drug effects
  • G(M1) Ganglioside / isolation & purification
  • G(M1) Ganglioside / pharmacology*
  • Interleukin-2 / pharmacology
  • Killer Cells, Lymphokine-Activated / drug effects
  • Killer Cells, Lymphokine-Activated / immunology
  • Lymphocyte Activation / drug effects*
  • Mice
  • Mice, Inbred C57BL
  • Receptors, Interleukin-2 / biosynthesis
  • Receptors, Interleukin-2 / drug effects*

Substances

  • Interleukin-2
  • Receptors, Interleukin-2
  • G(M1) Ganglioside